MediaPost – Should Pharma Brands Go Dark, Stop Advertising And Marketing During COVID-19 Pandemic?

When CMI/Compas asked whether consumers felt it was appropriate for the pharmaceutical industry to continue to provide branded and sponsored information and advertising related to their products during the COVID-19 pandemic, 74% agreed that it was OK, and of those, 36% highly agreed. As the world continues to fight COVID-19, people also must deal with other ailments and life-threatening situations that cannot be ignored, such as diabetes, heart disease, and cancer.

Click here to read the full article.